Concepedia

COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America

Ricardo Alonso, Berenice Silva, Orlando Garcea, Patricio E. Correa Diaz, Giordani Rodrigues dos Passos, Deyanira A. Ramírez Navarro, Luis A Garcia Valle, Luis C. Rodríguez Salinas, Laura Negrotto, Geraldine Luetic,

Multiple Sclerosis and Related Disorders · 2021 · 40 citations · 12 references

DOIFull text

Open access

Concepts

References

12

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

Gustavo Luna, Peter Alping, Joachim Burman et al. · JAMA Neurology · 2019 · 509 citations · Full text

, , +10

Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis

Céline Louapre, Nicolas Collongues, Bruno Stankoff et al. · JAMA Neurology · 2020 · 466 citations · Full text

, , +14

Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic

Wallace Brownlee, Dennis Bourdette, Simon Broadley et al. · Neurology · 2020 · 210 citations · Full text

, , +14

An Italian programme for COVID-19 infection in multiple sclerosis

Maria Pia Sormani · The Lancet Neurology · 2020 · 195 citations · Full text

, , +9

The COVID-19 pandemic and the use of MS disease-modifying therapies

Gavin Giovannoni, Chris Hawkes, Jeannette Lechner‐Scott et al. · Multiple Sclerosis and Related Disorders · 2020 · 191 citations · Full text

, , +11